Leerink Partners
An Equity Research Associate in Emerging Immunology conducts fundamental analysis and scientific diligence on biotech companies developing novel therapies for autoimmune diseases and inflammation. The role involves building financial models, authoring research reports for institutional clients, and engaging with stakeholders to communicate investment views in a fast-paced environment.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
1995
Leerink Partners is an investment bank uniquely dedicated to serving innovation-driven and growth-minded healthcare companies.
Leerink Partners Adds Timothy Michel to Trading and Execution Team
Nov 18, 2025
Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
3 days ago
Leerink Partners reiterates Ardelyx stock rating on pipeline progress
21 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Leerink Partners.
17% above the average for this role
He was on the brink amid SVB’s collapse. Now, Jeff Leerink’s firm leads the pack in health care deals.
2 weeks ago
Ventures Associate Director in Immunology and Inflammation
Schrödinger
POSTDOCTORAL RESEARCHER - Center for Cellular Therapies and Cancer Immunology - Choi Lab [Req#: 846073, Position#: 126042]
UT Southwestern Medical Center
Immunology Pipeline MSL
AstraZeneca
Scientific Director, Precision Medicine - Immunology
AbbVie
Associate Scientist, Immunology & Inflammation
Regeneron Pharmaceuticals
TEMP - Scientist, Immunology
Neurocrine Biosciences